Erschienen in:
Open Access
01.12.2015 | Poster presentation
Clinical experience of using a novel extracorporeal cytokine adsorption column for treatment of septic shock with multiorgan failure
verfasst von:
P Sathe, P Sakhavalkar, S Kumar, S Choudhary
Erschienen in:
Critical Care
|
Sonderheft 1/2015
Einloggen, um Zugang zu erhalten
Excerpt
Severe sepsis and multiorgan failure (MOF) are major causes of death in the ICU. The extracorporeal cytokine adsorption column (ECAC; Cytosorb®, CytoSorbents Corporation, USA), a critical care focused therapeutic device, results in rapid in vitro and in vivo elimination of several key cytokines and prevents organ failure. Use of ECAC in patients with sepsis is a new area of research with insufficient data to promote large prospective RCTs. Studies published to date have shown promising results. We report our clinical experience with ECAC for severe sepsis/septic shock/MOF patients. …